New England Surgical Society (NESS)
Search NESS
  Home
  Annual Meeting
  Annual Resident and Fellow Research Day
  Members
      Member Directory
      Members Only
  Scholars Foundation
  Job Board
  Awards
  Journal of the American College of Surgeons
  Newsletters
  Committees
  Contact NESS

2008 Annual Meeting Abstracts


Cumulative Initial Experience Using Hyaluronate-Iodine Complex in Wound Healing
Robert A. Brenes, MD, Michael S. Ajemian, MD, FACS, Stanley J. Dudrick, MD, FACS.
Saint Mary's Hospital, Waterbury, CT, USA.

Objective:
To study the efficacy of hyaluronate-iodine complex, a wound healing agent currently approved for use in the European Union, on different types of wounds.
Design:

Prospective study of sequentially accrued patients.
Setting:
Community teaching hospital.
Patients:

Fourteen patients with indolent wounds were recruited from the hospital, outpatient center, and the wound healing center.
Interventions:

Hyaluronate-iodine soaked gauze was applied to wounds either daily or every other day. Wounds were measured weekly and progression was documented with digital photography. All wounds were debrided as needed using standard techniques.
Main Outcome Measures:

Decrease in wound area and complete wound healing.
Results:

Fourteen patients (nineteen wounds) have been entered into our prospective study. Nine patients (twelve wounds) have completed treatment. Of the twelve wounds, eleven have gone on to complete healing with a mean healing time of 21 ± 20.82 weeks. Treatment was discontinued in one patient due to burning/painful application of ointment after twenty-two weeks with 20.2% wound area remaining to heal. Five patients (seven wounds) are still undergoing treatment satisfactorily.
Conclusions:

Hyaluronate-iodine is effective in healing all types of wounds studied. Enhanced and accelerated wound healing was noted in both chronic and acute wounds. The anti-adhesive and antimicrobial properties of hyaluronate-iodine are believed to create a desirable environment conducive to natural wound healing. Further studies are being conducted to determine the efficacy of wound healing with hyaluronate-iodine complex as compared to other wound healing agents.
Type of WoundLength of Treatment
Patient 1
Patient 1
Chronic venous insufficiency wound
Acute venous insufficiency wound
62 weeks
33 weeks
Patient 2Chronic left groin wound18 weeks
Patient 3Chronic traumatic pre-tibial wound50 weeks
Patient 4
Patient 4
Chronic venous insufficiency wound
Traumatic lower extremity wound
20 weeks
18 weeks
Patient 5
Patient 5
Burn to thigh
Burn to thigh
7 weeks
7 weeks
Patient 6
Patient 6
Diabetic foot ulcer
Diabetic foot ulcer
Still undergoing treatment (10 weeks)
Still undergoing treatment (10 weeks)
Patient 7Perianal fistula with abscess, excision of anorectal fistula4.5 weeks
Patient 8Surgical abdominal wound3.5 weeks
Patient 9
Patient 9
Surgical abdominal wound
Surgical abdominal wound
Still undergoing treatment (11.5 weeks)
Still undergoing treatment (11.5 weeks)
Patient 10Surgical abdominal woundDiscontinued after 22 weeks
Patient 11Chronic diabetic foor ulcer, osteomyelitis, MRSAStill undergoing treatment (7 weeks)
Patient 12Venous ulcerStill undergoing treatment (6 weeks)
Patient 13Diabetic foot ulcerStill undergoing treatment (4 weeks)
Patient 14Diabetic leg ulcer5 weeks


 

Copyright © 2018 New England Surgical Society. All Rights Reserved.
Read Privacy Policy.